Skip to main content

Foreign exchange

In defence of VAR

High profile losses such as those at hedge fund Amaranth last year had people questioning risk management tools, particularly value-at-risk. But Chris Schlegel and Andrew Kosnaski believe VAR would have given adequate signals to traders in the volatile…

Christopher Allsopp

The Director of the Oxford Institute for Energy Studies talks to Oliver Holtaway about his fresh approach to energy analysis

GMO's emerging market high-flyers

Bill Nemerever and Tom Cooper, co-managers of GMO's emerging markets debt portfolio, have made their names sourcing cheap debt in unusual locations. Shunning roadshows and local currencies, they barely even travel to the countries they invest in. Dalia…

Talkingpoint - 2007 outlook

Change is in the air for 2007. A deterioration in credit quality and concomitant rise in default rates may presage a tough year. We asked five leading market participants for their outlook

Back to basics

We take you back to the credit basics to review everything you thought you already knew but were too afraid to ask... In the second of a two-part series on credit derivatives, Saul Doctor, analyst at JPMorgan in London, discusses next-level CDS

Geoffrey Gwin

The clues to bond selection are in a firm's income statement, says the chairman of hedge fund Group G Capital Partners. He talks to Dalia Fahmy about his $115m long/short high-yield fund

Robert Lepone

The head of European loan trading at Morgan Stanley in London discusses issues surrounding the new loan CDS indices

CPDOs: A volatility game

A triple-A rated structure that pays Libor plus 200bp. Who wouldn't be interested in such a product? Perhaps the sceptics warning against the 15 times leverage and the instrument's high exposure to volatility. Laurence Neville reports

A state of equilibrium

Flows in the tranche market have balanced out - at least for now. Our US columnist StreetCred wonders whether valuation discrepancies may soon upset the applecart

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here